Home › Funds › CADEN CAPITAL PARTNERS, LP › ELV

CADEN CAPITAL PARTNERS, LP position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

CADEN CAPITAL PARTNERS, LP reported holding 564 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$218K, representing 2.63% of its reported portfolio and ranking #23 among its reported holdings. CADEN CAPITAL PARTNERS, LP has disclosed ELV holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)564 sh
Reported value held$218.12K
Portfolio Weight2.63%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CADEN CAPITAL PARTNERS, LP's ELV position evolved

CADEN CAPITAL PARTNERS, LP first disclosed a stake in ELV in Q4 2025 at 287 shares (US$101K). The position peaked in Q1 2026 at 864 shares, worth US$253K. Across 3 filings, CADEN CAPITAL PARTNERS, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 564 shares valued at US$218K — a reduction of -300 shares quarter over quarter.. Notable position changes include a 201% increase in Q1 2026 (shares rose 33% over the following quarter), a 35% trim in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 287 $100.61K New
Q1 2026 864 $252.94K Add
Q2 2026 564 $218.12K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has CADEN CAPITAL PARTNERS, LP held ELV?

CADEN CAPITAL PARTNERS, LP has disclosed ELV holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is CADEN CAPITAL PARTNERS, LP's current position in ELV?

As of Q2 2026, CADEN CAPITAL PARTNERS, LP holds 564 shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $218.12K, representing 2.63% of its reported portfolio and ranking #23.

Has CADEN CAPITAL PARTNERS, LP been buying or selling ELV?

In the latest 13F filing (Q2 2026), CADEN CAPITAL PARTNERS, LP reduced its position in ELV. The position peaked in Q1 2026 at 864 shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.